Karl Johe und Neuralstem - Info zur Person

(1 - 25 von 40

)

Zellen von Neuralstem Inc. überleben und werden zu Neuronen bei...

www.finanznachrichten.de

Zellen von Neuralstem Inc. überleben und werden zu Neuronen bei ...

www.bionity.com

"Vom Rückenmark wurde bislang angenommen, dass es für neuronale Stammzelltransplantate feindlich sei", kommentierte Dr. Karl Johe, wissenschaftlicher Gründer und Chairman von Neuralstem und ein Koautor der Studie ...

Neuralstem CSO, Dr. Karl Johe, To Speak At 6thNeurodegenerative...

www.finanznachrichten.de

11, PRNewswire/ --Neuralstem, Inc. (NYSE MKT: CUR) announced that Karl Johe, PhD, will give an update on the NSI-189 ongoing ...

One moment, please...

www.disabled-world.com

Karl Johe, PhD, Neuralstem's Chairman and Chief Scientific Officer, explained the scientific rationale behind the Neuralstem therapy.

Facebook: Neuralstem's CSO, Karl Johe, PhD, to Neuralstem, Inc. - Facebook

Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial

www.prnewswire.com

... directly into the gray matter of the spinal cord in the cervical region," said Karl Johe, PhD, Neuralstem's Chairman and Chief Scientific Officer.

Neuralstem CSO, Dr. Karl Johe, To Speak At 6th Neurodegenerative...

www.advfn.com

WLTGQ Neuralstem, Inc. Neuralstem CSO, Dr. Karl Johe, To Speak At 6th Neurodegenerative Conditions Research and Development Conference

Karl JOHE | Neuralstem, Rockville | Research profile

www.researchgate.net

Karl JOHE | Cited by 4,323 | of Neuralstem, Rockville | Read 68 publications | Contact Karl JOHE

Karl Y. Johe - Biography

www.marketscreener.com

Founder of Neuralstem, Inc., Karl Y. Johe is Chief Scientific Officer at this company. Dr. Johe previously held the position of Staff Scientist-Molecular...

IN THE UNITED STATES DISTRICT COURT FOR THE...

www.patentdocs.typepad.com

FOR THE DISTRICT OF MARYLAND SOUTHERN DIVISION : NEURALSTEM, INC., : Great Seneca Highway, : Rockville ... Dr. Karl Johe. Neuralstem’s technology

Alliance for Regenerative Medicine (ARM) Neuralstem Presentation |...

spinalcordresearchandadvocacy.wordpress.com

Try watching this video on www.youtube.com, or enable JavaScript if it is disabled in your browser. Karl Johe, Ph.D., Chief Scientific Officer

American Academy of Neurology: Annual Meeting | ALZFORUM

www.alzforum.org

The hope, said Neuralstem chief operating officer Karl Johe, is that the stem cells will prolong survival of motor neurons. “The graft will reach ...

NeuralStem presents on ALS treatment progress | Awesome Investors

awesomecapital.wordpress.com

... announced that Karl Johe, Ph.D., Neuralstem's Chairman and Chief Scientific Officer, provided an update on the company's ongoing NSI

Karl K. Johe's research works | Neuralstem, Inc., Maryland and other ...www.researchgate.net › scientific-contributions › Karl-K-Johe

www.researchgate.net

Karl K. Johe's 6 research works with 84 citations and reads, including: EFFECTS OF THE NEUROGENIC MOLECULE NSI-189 ON INDICES OF COGNITION IN AN ...Missing: Kaiserslautern" | Must include:Kaiserslautern" Karl K. Johe's 6 research works with 84 citations and reads, including: EFFECTS OF THE NEUROGENIC MOLECULE NSI-189 ON INDICES OF COGNITION IN AN ... Missing: Kaiserslautern" | Must include:Kaiserslautern"

NeuralStem Inc. CSO, Dr. Karl Johe, to Speak at 6th...

www.biospace.com

NeuralStem Inc. CSO, Dr. Karl Johe, to Speak at 6th Neurodegenerative Conditions Research and Development Conference - read this article along with other...

Karl Y. Johe - Biographie

www.zonebourse.com

Founder of Neuralstem, Inc., Karl Y. Johe is Chief Scientific Officer at this company. Dr. Johe previously held the position of Staff Scientist-Molecular...

Karl Johe – Missouri Cures Education Foundation

missouricures.org

Monday, July 2, By: Gazette staff Neuralstem, the Rockville company that's developing a stem cell treatment for patients with amyotrophic lateral sclerosis, ...

Companies Provide Updates for Stem Cells Clinical Trials | Stem...

stemcellsportal.com

... of the second quarter and then begin the transplantations,” Karl Johe, Ph.D., Neuralstem's chairman of the board and chief scientific officer.

FDA Approves Phase II Stem Cell Trial for Lou Gehrig’s Disease

www.medicaldaily.com

The most ever stem cells transplanted into a human has been approved by the Food and Drug Administration. Neuralstem, Inc. will begin a Phase II clinical trial...

Human Neural Stem Cell Transplantation in Traumatic Brain Injury -...

www.themiamiproject.org

... proprietary regionally specific stem cells and their potential benefits in nervous system disorders,” said Karl Johe, Ph.D., Chief Scientific Officer, Neuralstem.

Neural Stem Cell Therapy for Severe Traumatic Brain Injury | SBIR.gov

www.sbir.gov

Principal Investigator. Name: KARL JOHE Phone: (301) Business Contact. Name: Rich Daly Phone: (301)

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect...

clinicaltrials.gov

Study Director: Karl Johe, PhD, Neuralstem Inc. More Information. Publications: Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas ...

Neuralstem's Cells Induce Improvement In Acute Spinal Cord Injury...

pipelinereview.com

Neuralstem's Cells Induce Improvement In Acute Spinal Cord Injury Rats, UCSD Study Shows

Neuralstem's NSI-189 Trial In Major Depressive Disorder Receives FDA...

www.clinicalleader.com

Neuralstem's NSI-189 Trial In Major Depressive Disorder Receives FDA Approval To Advance To Phase Ib - Neuralstem, Inc.

Neuralstem Stock Forecast, Price & News (NASDAQ:CUR)

www.marketbeat.com

, Karl Johe, Insider, Sell, 25,000, $1.09, $27View SEC Filing , Karl Johe, Insider, Sell, 25,000, $1.18, $29,

Alle Infos zum Namen "Karl Johe"

Verwandte Suchanfragen zu Karl Johe

Personen
Vorname "Karl" (41379)
Name "Johe" (81)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Karl Johe und Neuralstem Person-Info